Sleep: What the Evidence Says

Sleep has 4 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, government publ

5 min read · 833 wordsReviewed May 2026
White letter tiles spelling 'SLEEP' against a dark navy background, highlighting simplicity and rest. - Evidence evidence guide for Sleep: What the Evidence Says
Photo by Ann H on Pexels · Pexels License

Quick Answer

Sleep has 4 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, government public health, so conclusions should be framed as evidence aware guidance rather than medical advice.

Key Takeaways

  • 01This page is generated only from sources stored in the Migaku evidence knowledge base.
  • 02Current evidence mix: 2 government public health, 1 randomized trial, 1 research article.
  • 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
  • 04This article is educational and does not replace care from a qualified clinician.

Sleep: What the Evidence Says

Quick Answer

Sleep has 4 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, government public health, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

  • This page is generated only from sources stored in the Migaku evidence knowledge base.
  • Current evidence mix: 2 government public health, 1 randomized trial, 1 research article.
  • Claims should be interpreted with the source type, study design, population, and publication date in mind.
  • This article is educational and does not replace care from a qualified clinician.

Evidence Map

Source Evidence type Level Date Identifier
The Effect of Progressive Relaxation Exercises Applied to Individuals With Type 2 Diabetes on FATIQUE Level and Sleep Quality: A Randomised Controlled Study randomized trial 2 2026-04-06 10.1111/scs.70220
Nursing Pillows in the Sleep Environment and Sudden Unexpected Infant Deaths — Georgia, January 2013–December 2022 government public health 2 2025-05-30 759452
Notes from the Field: Rhodesiense Human African Trypanosomiasis (Sleeping Sickness) in a Traveler Returning from Zimbabwe — United States, August 2024 government public health 2 2025-03-28 758439
Clinical Care Interaction and Patient Sleep in the Intensive Care Unit: A Secondary Data Analysis research article 4 2026-04-13 10.1111/nicc.70482

What The Sources Report

  • Fatigue in diabetes is a distressing problem that can result from physiological abnormalities like hypoglycemia, hyperglycemia, or fluctuations between the two. [Vardar inkaya Bahar (2026); evidence level 2]
  • As a result of the post hoc power analysis performed using the G*Power 3.0.10 program; the power of the study was found to be sufficient as 83.1% with a 5% margin of error and the determined effect size in a 2-group, 2-repetition study design. [Vardar inkaya Bahar (2026); evidence level 2]
  • Analysis of Child Death Review data found that among 1,685 SUIDs in Georgia during 2013–2022, a nursing pillow was in the infant’s sleep space in 84 (5%) cases. [DEPUTY DIRECTOR FOR PUBLIC HEALTH SCIENCE AND SURVEILLANCE (2025); evidence level 2]
  • Pediatric National Fatality Review Case Reporting System (NFR-CRS) data ( 4 ) found that during this period, a nursing pillow was present in association with 141 sleep-related deaths nationwide ( 5 ). [DEPUTY DIRECTOR FOR PUBLIC HEALTH SCIENCE AND SURVEILLANCE (2025); evidence level 2]
  • The implications of sleep disturbance are not benign and have been linked with a myriad of adverse effects, including impaired immune responses, metabolic disturbances, delirium, psychological distress and increased mortality. [Islam Aliya (2026); evidence level 4]
  • Intrinsic factors encompass the complex interplay of physiological responses to critical illness resulting in increased inflammatory biomarkers (cytokines, interleukins, C-reactive protein), which disrupt circadian rhythms and the homeostatic drive that co-ordinates normal sleep. [Islam Aliya (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. CDC material can support public-health framing, but it should not be used as product endorsement. For sleep, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.

FAQ

Frequently Asked Questions

M

Medically reviewed

Last reviewed May 20, 2026 by Migaku Evidence Review

← All GuidesSupplement Reference →